» Articles » PMID: 36912009

Updated Psychosocial Surveys With Continuous Glucose Monitoring Items for Youth With Type 1 Diabetes and Their Caregivers

Overview
Specialty Endocrinology
Date 2023 Mar 13
PMID 36912009
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: We added items relevant to continuous glucose monitoring (CGM) to the Diabetes Family Conflict Scale (DFC), Diabetes Family Responsibility Questionnaire (DFR), and Blood Glucose Monitoring Communication Questionnaire (GMC) and evaluated the psychometric properties of the updated surveys.

Research Design And Methods: Youth with type 1 diabetes who recently started CGM and their parents completed the updated surveys and additional psychosocial surveys. Medical data were collected from self-reports and review of the medical record.

Results: Youth (N = 114, 49% adolescent girls) were aged 13.3 ± 2.7 years and had mean glycated hemoglobin (HbA1c) 7.9 ± 0.9%; 87% of them used pump therapy. The updated surveys demonstrated high internal consistency (DFC youth: α = .91, parent: α = .81; DFR youth: α = .88, parent: α = .93; and GMC youth: α = .88, parent: α = .86). Higher youth and parent DFC scores (more diabetes-specific family conflict) and GMC scores (more negative affect related to glucose monitoring) were associated with more youth and parent depressive symptoms ( = 0.28-0.60, ≤ .003), more diabetes burden ( = 0.31-0.71, ≤ .0009), more state anxiety ( = 0.24 to = 0.46, ≤ .01), and lower youth quality of life ( = -0.29 to -0.50, ≤ .002). Higher youth and parent DFR scores (more parent involvement in diabetes management) were associated with younger youth age (youth: = -0.76, < .0001; parent: = -0.81, < .0001) and more frequent blood glucose monitoring (youth: = 0.27, = .003; parent: = 0.35, = .0002).

Conclusions: The updated DFC, DFR, and GMC surveys maintain good psychometric properties. The addition of CGM items expands the relevance of these surveys for youth with type 1 diabetes who are using CGM and other diabetes technologies.

References
1.
. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2021; 45(Suppl 1):S83-S96. DOI: 10.2337/dc22-S006. View

2.
Mehta S, Nansel T, Volkening L, Butler D, Haynie D, Laffel L . Validation of a contemporary adherence measure for children with Type 1 diabetes: the Diabetes Management Questionnaire. Diabet Med. 2015; 32(9):1232-8. PMC: 4802856. DOI: 10.1111/dme.12682. View

3.
Markowitz J, Volkening L, Butler D, Laffel L . Youth-Perceived Burden of Type 1 Diabetes: Problem Areas in Diabetes Survey-Pediatric Version (PAID-Peds). J Diabetes Sci Technol. 2015; 9(5):1080-5. PMC: 4667338. DOI: 10.1177/1932296815583506. View

4.
Laffel L, Kanapka L, Beck R, Bergamo K, Clements M, Criego A . Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial. JAMA. 2020; 323(23):2388-2396. PMC: 7298603. DOI: 10.1001/jama.2020.6940. View

5.
Varni J, Burwinkle T, Jacobs J, Gottschalk M, Kaufman F, Jones K . The PedsQL in type 1 and type 2 diabetes: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales and type 1 Diabetes Module. Diabetes Care. 2003; 26(3):631-7. DOI: 10.2337/diacare.26.3.631. View